Search clinical trials for: postmenopausal patients

Total 107439 results

Merrimack Pharmaceuticals

Completed

Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer

Her2 Negative Breast Cancer Patients

United States, Spain, Canada, Germany, Russian Federation
Novartis Pharmaceuticals

Terminated

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1) (MONALEESA-1)

Early Breast Cancer

Spain, Singapore, United States
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR)

Completed

Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole

Breast Cancer

Canada
Hellenic Breast Surgeons Society

Completed

Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy (COPA)

Breast Cancer

Greece
Vejle Hospital

Completed

Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture

Breast Cancer | Postmenopause

Denmark
Arbeitsgemeinschaft medikamentoese Tumortherapie
Roche Pharma AG

Completed

Exercise Training in Postmenopausal Patients With Breast Cancer

Physical Activity

Austria
National Cancer Institute (NCI)

Terminated

RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast Carcinoma

United States
Pfizer

Terminated

Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer

Early Breast Cancer (Phase 2) | Advanced Breast Cancer (Phase 1b)

Spain, Sweden, Italy, Belgium
AstraZeneca

Completed

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

Breast Cancer

United States, Mexico, Venezuela, Colombia
AstraZeneca

Completed

A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer (ACT-FASTER:)

Breast Cancer | Postmenopause

Germany
AstraZeneca

Completed

Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment (BC Qol NIS)

Breast Cancer

China
Genzyme, a Sanofi Company

Terminated

An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass

Osteoporosis

United States
Universitaire Ziekenhuizen KU Leuven

Completed

A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors and Tamoxifen (LOGRIBMET)

Breast Cancer | Arthralgia

Belgium
Institut fuer Frauengesundheit
Novartis; ClinSol

Unknown

Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace) (PreFace)

is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.

Germany
Warner Chilcott
Sanofi

Completed

Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate

Postmenopausal Osteoporosis

United States, Canada
Pfizer

Terminated

Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

Early Breast Cancer
AstraZeneca

Completed

Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer (RADAR II E)

Breast Cancer

Hungary
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Pfizer

Terminated

A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients (ETAPE)

Breast Cancer
Pfizer

Completed

Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy (TAMARA)

Breast Neoplasms

Turkey
Hellenic Oncology Research Group

Completed

Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer

Breast Cancer

Greece
Novartis

Completed

Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

Osteoporosis | Postmenopausal

Germany
Soroka University Medical Center
Tel-Aviv Sourasky Medical Center

Completed

Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole

Breast Cancer

Israel
Regina Elena Cancer Institute
AstraZeneca

Unknown

A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC) (FIDeS)

Breast Cancer

Italy
National Cancer Center, Korea

Completed

Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC

Metastatic Breast Cancer

Korea, Republic of
Novartis

Terminated

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Macular Degeneration | Choroidal Neovascularization

United Kingdom, Spain, Netherlands, Hungary, Italy, Denmark, Belgium, Austria, France, Germany, Poland, Switzerland
Sanofi

Terminated

Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer

Breast Neoplasms

France, Italy, Spain
AstraZeneca

Completed

Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer (@FAME)

Breast Cancer

Germany, Norway, Austria
AstraZeneca

Completed

Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients (SOSTA)

Breast Cancer
Tuen Mun Hospital
Eli Lilly and Company

Completed

Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy

Osteoporosis

China
AstraZeneca

Completed

10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)

Breast Cancer

Korea, Republic of
AstraZeneca

Completed

Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer (TIME 2 CHANGE)

Breast Cancer | Post Menopausal

Italy
Korean Breast Cancer Study Group

Unknown

Assessment of Quality of Life, Bone Density and Safety in Postmenopausal Breast Cancer Patients With Letrozole Therapy

Breast Cancer

Korea, Republic of
AstraZeneca

Completed

Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg

Breast Cancer
National Center for Research Resources (NCRR)
Pfizer; Alzheimer's Association; Eisai Inc.

Completed

Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease

Alzheimer Disease

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.

Postmenopausal Osteoporosis
Chang Gung Memorial Hospital

Unknown

Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood Pressure

Hypertension | Menopause

Taiwan
Chungnam National University Hospital
AtoGen Co. Ltd

Recruiting

The Effect of Probiotics ATG-F4 in Cancer Patients

Pancreatic Cancer | Colon Cancer

Korea, Republic of
Henan Cancer Hospital

Recruiting

An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer

Non-Small Cell Lung Cancer

China
Sichuan Baili Pharmaceutical Co., Ltd.
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Head and Neck Squamous Cell Carcinoma

China
Foundation University Islamabad

Recruiting

Effects of Sustained Natural Apophyseal Glides Combined With Kinesiotaping in Patients With Chronic Mechanical Neck Pain: A Randomised Controlled Trial

Neck Pain

Pakistan
Elsan

Not yet recruiting

Impact of Mindfulness-Based Stress Reduction Meditation Practice on Patients After Cardiac Rehabilitation. (CARDIO-MBSR)

Cardiac Disease

France
Laval University
Université de Montréal

Not yet recruiting

Music Intervention in Chronic Pain Patients (MusicCPP)

Chronic Pain | Anxiety | Well-Being, Psychological
Hanmi Pharmaceutical Company Limited

Recruiting

A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients With Essential Hypertension (HM_APOLLO)

Hypertension

Korea, Republic of
Sichuan Baili Pharmaceutical Co., Ltd.
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer

Extensive-stage Small-cell Lung Cancer

China
Foundation University Islamabad

Recruiting

Comparison of Effectiveness Between Active Release Technique and Hold Relax Technique in Patients With Piriformis Syndrome

Piriformis Syndrome

Pakistan
Postgraduate Institute of Dental Sciences Rohtak

Not yet recruiting

Impact of MINST With and Without Splinting in Periodontitis Patients With Mobile Anterior Teeth

Periodontitis | Tooth Mobility

India
University of Pecs
National Institute of Mental, Neurological and Neurosurgery; Borsod-Abaúj-Zemplén...

Recruiting

The Investigation of the Impact of Early Mobilization on the Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage.

Subarachnoid Hemorrhage, Aneurysmal | Early Ambulation | Standard of Care

Hungary
Xi Chen
Harbin Medical University

Not yet recruiting

Effects of Appropriate Technology for Home-based Rehabilitation in Patients With Post-stroke Physical Dysfunction

Stroke
Odense University Hospital
Center for Digital Psykiatri

Not yet recruiting

Use of an Online Intervention for the Treatment of Diabetes Distress in Patients With Type 1-Diabetes

Diabetes Mellitus, Type 1 | Diabetes Distress

Denmark

3

Subscribe